tiprankstipranks
Trending News
More News >
Avadel Pharmaceuticals (AVDL)
NASDAQ:AVDL

Avadel Pharmaceuticals (AVDL) Revenue

Compare
800 Followers

Avadel Pharmaceuticals Revenue

Avadel Pharmaceuticals had a revenue of 77.47M in the quarter ending Sep 30, 2025, with 13.71%. This bring the company's revenue in the last twelve months to 248.52M, Decreased 12.41%. In the fiscal year ending Dec 31, 2024, Avadel Pharmaceuticals had annual revenue of 169.12M with 504.79% growth.
Revenue (ttm)
248.52M
Revenue Growth
79.88%
P/S Ratio
12.35
Revenue/Employee
$899,559
Employees
188
Market Cap
$2.09B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
169.12M141.15M+604.79%
Dec 31, 2023
27.96M-2,796,300,000.00%
Dec 31, 2022
Dec 31, 2021
-22.33M
Dec 31, 2020
22.33M-36.88M+37.72%
Dec 31, 2019
59.22M-44.05M+57.34%
Dec 31, 2018
103.27M-69.47M+59.78%
Dec 31, 2017
172.74M22.50M+114.97%
Dec 31, 2016
150.25M